1 / 23

GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION

GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION. K. Boukef ATMC 10 Kuwait 28/11 – 1/12/2012. DEFINITION. A  MONOPOLY (FROM GREEK  MONOS  ΜΌΝΟΣ (ALONE OR SINGLE) +  POLEIN  ΠΩΛΕῖΝ (TO SELL) EXISTS WHEN THERE IS THE ONLY SUPPLIER OF A PARTICULAR COMMODITY . DEFINITION.

freja
Download Presentation

GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GOVERNMENT MONOPOLYOFBLOOD TRANSFUSION K. Boukef ATMC 10 Kuwait 28/11 – 1/12/2012

  2. DEFINITION • A MONOPOLY (FROM GREEK MONOS ΜΌΝΟΣ (ALONE OR SINGLE) +  POLEIN ΠΩΛΕῖΝ (TO SELL) EXISTS WHEN THERE IS THE ONLY SUPPLIER OF A PARTICULAR COMMODITY 

  3. DEFINITION • A GOVERNMENT MONOPOLY (OR PUBLIC MONOPOLY) WHEN A GOVERNMENT AGENCY OR GOVERNMENT CORPORATION IS THE SOLE PROVIDER OF A PARTICULAR GOOD OR SERVICE AND COMPETITION IS PROHIBITED BY LAW.

  4. DEFINITION • A MONOPOLY IS DISTINGUISHED FROM A MONOPSONY, IN WHICH THERE IS ONLY ONE BUYER OF A PRODUCT OR SERVICE ; • A MONOPOLY MAY ALSO HAVE MONOPSONY CONTROL OF A SECTOR OF A MARKET. (CENTRAL PHARMACY)

  5. A MONOPOLY IS A SINGLE SELLER

  6. EXAMPLES OF TUNISIAN GOVERNMENT MONOPOLY IN THE FIELD OF HEALTH

  7. TUNISIAN MONOPOLY IN THE FIELD OF HEALTH • 1) DRUG IMPORTATION (CENTRAL PHARMACY) • 2) BLOOD TRANSFUSION (NATIONAL BLOOD TRANSFUSION CENTRE / AND HOSPITAL BB)

  8. TUNISIAN REGULATION

  9. LEGAL MONOPOLY OF BLOOD TRANSFUSION IS ESTABLISHED BY LAW . IT ALLOWS YOU TO RESTRICT COMPETITION TO ACHIEVE POLICY OBJECTIVES SUCH AS SAFETY, PLANNING, MANAGING A STRATEGIC AND SOLIDARITY.

  10. LAW • LAW N° 82-26 MARCH 17TH 1982 CONCERNING, ORGANIZATION OF SAMPLING HUMAN BLOOD FOR TRANSFUSION

  11. Art 2) HUMAN BLOOD CAN BE COLLECTED WITH THE CONSENT, FREE AND CONSCIOUS OF THE PERSON CONCERNED, WITHOUT CONTERPART = BLOOD DONOR MUST BE VNRD

  12. Art 5 • BLOOD COLLECTION CAN BE PERFORMED ONLY IN INSTITUTIONS APPROVED FOR THE PURPOSE (LICENSING)

  13. 1 NBTC • 5 RBTC • 1 MBTC • 29 BB

  14. Art 7 • THE RECOVERY OF COSTS OF • PROCESSING, • ANALYSIS AND STORAGE OF BLOOD AND BLOOD COMPONENTS • TAKES PLACE UNDER CONDITIONS AND ACCORDING TO THE RATES SET BY ORDINANCES, MINISTERS OF FINANCE AND OF PUBLIC HEALTH ANDNOT GIVE RISE TO ANY PROFIT

  15. COST RECOVERY • SINCE 2008 NO CHANGE HAVE BEEN OPERATES IN THE ORDINANCE RELATED TO THE PRICE OF THE BLOOD COMPONENTS • THE PRICE OF SOME PRODUCT ARE UNDERESTIMATED

  16. ADVANTAGESOF GOVERNMENT MONOPOLY

  17. BLOOD TRANSFUSION SERVICES=CENTRALIZED AND COORDINATED

  18. STANDARDIZATION OF BT PRACTICES • ALL THE PROCEDURES STARTING FROM BLOOD DONATION, GOING THROUGH PROCESSING, STORAGE AND DISTRIBUTION. (SOP’S MANUAL) • ALL LAB TECHNICS ARE STANDARDIZED

  19. PURSHASING • PURCHASING CONSUMABLES IS STANDARDIZED AND CONSOLIDATE D THROUGH CENTRAL PHARMACY • BLOOD BAG ( SAME SUPPLIERS) CONTROLLED BY THE DRUG CONTROL NATIONAL LAB • REAGENTS : IMMUNOHEMATOLOGY/SEROLOGY ( SAME SUPPLIERS ) CONTROLLED BY THE NBTC REFERENCE LAB)

  20. BLOOD SAFETY REINFORCED • CONDUCTINGNATIONAL SURVEY RELATED TO • BLOOD DONATION ( CATEGORIES OF BLOOD DONORS) • TTI MARKERS (PREVALENCE AMONG DONORS) • FOLLOW UP INDICATORS ( NB OF VNRBD, % OF TTI ETC..;)

  21. NATIONAL POLICY • IMPLEMENTATION OF BLOOD DONATION STRATEGY (since 2008) • IMPLEMENTATION OF A HAEMOVIGILANCE NETWORK (since 2007) • COLLECTION OF SURPLUS OF PLASMA FOR CONTRACT FRACTIONATION (3 operations since 1999 )

  22. CONCLUSION • GOVERNMENT MONOPOLY HAS MANY ADVANTAGES • CENTRALIZED AND COORDINATED BT SERVICES • IMPLEMENTATION OF NATIONAL POLICY • ONLY ONE NATIONAL STRATEGY

  23. CONCLUSION • THE CHAIN OF CONSUMABLES IS UNDER CONTROL • STANDARDIZATION OF BLOOD TRANSFUSION PRACTICES • COST CONTROL AND SINGLE PRICE.

More Related